What We Do · BE Study Support
Bioequivalence (BE) Study Support
What We Do · BE Study Support
Bioequivalence (BE) Study Support
Enventor Research Lab provides bioequivalence support services to help clients plan, prepare and execute BE studies efficiently. While clinical studies are conducted through approved CROs, Enventor supports formulation optimization, analytical readiness and regulatory documentation.
Our integrated approach ensures successful BE outcomes, reduces risk of study failure and rework, and supports timely regulatory approvals.
Core Capabilities
Integrated services delivered with scientific rigor
01
BE Formulation Development
- Selection and optimization of BE-ready formulations
- Comparative dissolution and in-vitro testing
- Formulation matching to RLD characteristics
- Stability support for clinical trial material
02
Analytical Readiness
- Analytical method development and validation for BE samples
- Comparative dissolution reporting
- Bioanalysis laboratory support
- Sample logistics for clinical trial material
03
CRO Coordination
- Coordination with CROs for clinical study execution
- Protocol review and scientific input
- Oversight during clinical execution
- Experience with BE regulatory expectations
Typical Timeline
How a typical engagement unfolds
01
BE formulation development
6–10 weeks
02
Analytical method readiness
3–6 weeks
03
Comparative dissolution
2–4 weeks
04
Clinical material & stability
4–8 weeks
05
CRO coordination & study
Project-dependent
06
BE documentation
2–4 weeks
BE formulation and analytical preparation typically span 2–4 months; clinical study coordination is project-dependent.
Get in touch
Partner with Enventor on your next program
From early development through commercialization — backed by science, quality, and regulatory expertise.
Get in touch